InvestorsHub Logo

Inoviorulez

10/31/15 10:26 AM

#119115 RE: Shadowfaxin #119114

I can't argue you with you on that statement. For instance what's up with posting that ESS news for 13 year followup. Old news rehashed to boost share price. Anyways AMBS shouldn't be focusing on a dermatology indication ESS. Should be focusing on its neorology pipeline.

sante1

10/31/15 10:48 AM

#119116 RE: Shadowfaxin #119114

Never the less Gerald ha failed. One thing he has won. No one will trust him anymore.

A man a man, a word a word, That's certainly not him.

He has a lot to explain. If he fails this time it's over and out.

One thing is for sure this is not the way, you communicate. He put us on purpose on the wrong leg.

My advice, Gerald step down, you lost all your credibility, you can't do as if nothing did happen.